Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. Rev Diabet Stud [Internet]. 2025 Dec. 6 [cited 2026 Jul. 22];:496-510. Available from: https://www.diabeticstudies.org/index.php/RDS/article/view/2052